I. INTRODUCTION
production, the benefits of ST include effects on environmental impact through reductions in animal waste products and expenditures for feed production, including fertilTechnological developments in a variety of scientific izer and other inputs associated with growing, harvesting, and engineering disciplines will be needed to support the processing, and storing animal feed (13, 101) . growing world population, which is expected to double in Another important impetus for developing biotechthe next 40 years. It has been estimated that the supply of nologies for animal agriculture is the need to reduce the food required to adequately meet human nutritional needs fat content of fresh meat products. Numerous studies over the next 40 years is quantitatively equal to the amount have shown that ST effectively alters nutrient use in growof food previously produced throughout the history of huing animals in a manner that markedly reduces the amount mankind (137). To meet this need, it will be essential that of carcass fat. This is important because of the evidence scientists continue to develop new technologies that inthat certain saturated fatty acids (e.g., myristic and palcrease productive efficiency of food production. With remitic acids) found in animal fat potently elevate low-denspect to animal agriculture, administration of exogenous sity lipoprotein cholesterol levels, a major risk factor for somatotropin (ST) is one biotechnology that increases the coronary heart disease (4, 113) . Because animal products food output (meat or milk) per unit of feed resource input. In addition to positive effects on the efficiency of food provide Ç60-70% of the total saturated fatty acids in the Thus the sequence similarities among the pST, bST, and 100 220 134 hST receptors are much greater than for the respective hormones that bind to the homologous receptor. A numDose of porcine somatotropin (pST) represents daily dose. Adapted from Campbell et al. (34) .
ber of mRNA variants for the ST receptor have been reported for cattle (93) , sheep (142) , and other species including humans (189). Studies have shown that a single arginine residue in the hST receptor is the major determi-g/day), it is apparent that the biological capacity or ''ceilnant of species specificity in ST binding (164) .
ing'' (as estimated by maximally effective doses of pST) for protein accretion is still considerably greater than rates presently attained despite the impressive improve-
III. EFFICACY OF SOMATOTROPIN
ments that have occurred with genetic selection over the last several decades in protein accretion rate. This sug-A. Growth gests that considerable progress in increasing protein accretion rate can still be made with genetic selection programs that use protein accretion rate as a selection Somatotropin has been shown to have impressive effects on nutrient partitioning between muscle and adipose criterion.
The early studies evaluating the effects of pST on tissue that leads to a dramatic alteration in the growth of these tissues. Daily administration of maximally effective growth and carcass composition (40, 71, 73) suggested that responsiveness was age dependent. This has been doses of pST (¢100 mgrkg body wt 01 rday 01 ) to growing pigs for 30-77 days can increase average daily gain verified in subsequent studies ( Table 2 ) that have shown the increase in growth rate and effects on protein and lipid Ç10-20%, improve feed efficiency (i.e., the ratio of feed consumed to body weight gain) 13-33%, decrease lipid deposition with pST treatment are significantly greater in the latter phase of the growth cycle. The mechanisms that accretion rates by as much as 70%, and stimulate protein deposition (muscle growth) by as much as 62% (reviewed account for this remain unclear.
There is a good understanding of how changes in the in Refs. 66, 68, 137). In general, responses in lean tissue accretion to ST treatment have been less for growing ru-pST dose affect various parameters of growth, productive efficiency, and carcass composition (28, 73, 137). Collecminants than observed for pigs. However, this species difference appears to relate to the difficulty in ensuring tively, these studies have established that the dose relationship varies considerably among the different paramean amino acid supply that is adequate in balance and quantity. When the supply of rumen microbial protein is ters (see Fig. 1 ). For example, body weight growth and rate of protein accretion are maximally stimulated at a complemented with additional amino acids that escape rumen fermentation, the dramatic increase in protein ac-daily dose of pST of Ç100 mg/kg body wt. In contrast, lipid accretion rate and the ratio of feed consumed to cretion with bST treatment of ruminants is comparable to that observed with pST treatment of growing pigs (re-body weight decrease in a more linear manner over a range of pST up to 200 mg/kg body wt (see Fig. 1 ). The viewed in Refs. 27, 137).
It is evident that pST administration has dramatic fact that there are differences in the shape of the doseresponse curves is important because it illustrates that effects on protein accretion even in pigs highly selected for rapid growth and high rates of protein accretion (34). pST affects growth and nutrient metabolism of adipose tissue and muscle by different mechanisms. This is further This is vividly illustrated by the results in Table 1 , which show the effects of pST on rate of protein accretion in illustrated by how dietary protein restriction affects lipid and protein accretion in pST-supplemented pigs (Fig. 2) . pigs that are considered to be ''genetically elite'' for rapid protein accretion. In this study, boars (intact males) The stimulatory effects of pST on protein accretion and circulating insulin-like growth factor (IGF)-I are progrestreated with pST gained 273 g protein/day. This is the highest rate of protein deposition observed in pigs to date sively decreased until they are completely blunted as dietary protein levels decline (Fig. 2) . In contrast, the ability and corresponds to a muscle growth rate of Ç1.4 kg/day. When this rate of protein accretion rate is compared with of pST to reduce lipid accretion occurs across the range of dietary protein, even with the diets that contain the that observed for elite pigs not treated with pST (162 decreases the rate of adipocyte hypertrophy and, hence, tance of making adjustments in the dietary amino acidcalorie relationship to ensure an adequate availability of the rate of adipose tissue accretion and 2) accounts for the effects that ST has on productive efficiency as well essential amino acids to accommodate the enhanced rate of protein accretion. This is particularly important be-as contributes to the increase in muscle growth. cause this dose of pST decreases feed intake.
The precipitous decrease in lipid deposition (see the first few days of bST treatment and reaches a maximum during the first week. If treatment is terminated, milk yield gradually returns to pretreatment levels over a similar time period. However, when treatment is continued, the increased milk yield is maintained (Fig. 3) . Thus bST results in a greater peak milk yield and an increased persistency in yield over the lactation cycle. As a consequence of the changes in the lactation curve, commercial use of bST has allowed a shift to extended lactations. On a herd basis, this results in fewer parturitions, lower incidence of postpartum metabolic diseases, lower veterinary costs, and an overall improvement in herd life, animal well-being, and dairy farm profitability (171) .
Lactational response to bST is a function of the daily dose represented by a hyperbolic dose-response curve with a pattern of diminishing marginal returns to increasing doses (17, 129). The daily bST dose needed to optimize milk yield response results in blood concentrations of ST that are within the range typically observed during episodic release of endogenous hormone, but average daily concentrations are severalfold higher than before treatment. Milk yield response appears to be related to the average daily ST concentration rather than a particular from laboratory animals to humans (19, 85, 134) . In the case of farm animals, a milk yield response has been demonstrated with ST treatment of pigs, sheep, goats, and cows. The majority of research has involved dairy cows, and bST has been approved for commercial use in 25 countries. Additional countries have approved but have a political moritorium on its use, e.g., European Union (91) . Commercial use in the United States commenced in early 1994, and adoption was unusually rapid for an agricultural technology; Ç2 million dairy cows were receiving bST by 3 years postapproval.
Milk yield response to bST has been observed for all dairy breeds and in animals of different parity and genetic potential (30, 91, 137) . In general, response is negligible in early lactation before peak yield, so bST use is over the last 80% of the lactation cycle. Typical milk yield responses are increases of 10-15% (Ç4-6 kg/day), although even Studies have demonstrated a using a combination of artificial insemination (semen from superior sires) and embryo transfer (13) . similar milk yield increase regardless of whether the daily dose of bST was administered as a single bolus, constant infusion, or as equal episodic pulses at 4-h intervals (17).
IV. MECHANISMS OF SOMATOTROPIN ACTION The commercial form of bST presently used in the United
States is a prolonged-release formulation (500 mg methionyl-bST; Monsanto) that is administered every 2 wk (91).
The range of biological effects ST has on growth and The formulations of other companies are currently being lactation is extraordinary (Table 3) . Somatotropin orchesevaluated by the Food and Drug Administration.
trates many diverse physiological processes so that more The gross composition of milk (fat, protein, and lac-nutrients can be used for lean tissue accretion (during tose) is not altered by treatment with bST (9, 13, 30, 37, growth) or milk synthesis (during lactation). Somato-172). Thus the daily output of the major milk constituents tropin is a homeorhetic control that affects numerous taris increased by an amount comparable to the increase in get tissues in ways that are highly coordinated to affect milk volume. The concentrations of fat and protein in marked changes in nutrient partitioning among these tismilk normally vary as a result of factors such as genetics, breed, stage of lactation, season, diet, and nutritional sta- (milk per unit of feed) is improved because a greater proportion of the nutrient intake is used for milk synthesis F , Increase; f , decrease; IGF-I, insulin-like growth factor I; IGFBP, (13, 137 Table 3 ). These coordinated changes in tissue metabolism alter nutrient partitioning and thus play a key role ited daily in adipose tissue (66-68). Because pigs typically consume diets that are quite low in fat (Ç9% of calories vs. in increasing growth performance or milk yield.
The principal effect of ST is on partitioning of ab-Ç34% of calories for human diets), the majority (Ç80%) of lipid in the body is derived from de novo fatty acid synthesorbed nutrients. In lactating cows or growing cattle treated with bST, digestibilities of dry matter, carbon, ni-sis (141) , and adipose tissue is the major site of conversion of excess energy to fatty acids in both pigs and cattle (12, trogen, and energy are not altered (15, 26, 37, 61). The energy expenditure for maintenance or the partial effi-141). The extent of this is illustrated by isotope kinetic studies that have shown that ú40% of whole body glucose ciency of milk synthesis is not altered in dairy cows treated with bST (108, 170) . Likewise, studies with grow-turnover is being used by adipose tissue for de novo lipogenesis in 80-kg pigs (57). ing pigs and cattle have shown that the energetic efficiency of specific processes is not altered. However, mainOne mechanism by which somatotropin alters nutrient partitioning is to modulate tissue responsiveness to tenance costs at a given body weight are increased by pST administration in pigs that is consistent with the fact insulin. Somatotropin treatment reduces whole body glucose response when insulin tolerance tests are conducted that pST-treated animals have a greater proportion of lean tissue (27, 32, 176, 177) . (56, 84, 158) . This effect of ST is frequently referred to as insulin resistance, but this is somewhat misleading since The remainder of this review discusses the mechanisms by which ST exerts its biological effects. The objec-the effect is clearly tissue specific and relates to only tive is to provide an overview of the mechanisms; many previous reviews have addressed more specific aspects of ST action in domestic animals (19, 62, 65, 137).
A. Effects on Lipogenesis and Lipolysis
Somatotropin has dramatic effects on adipose tissue and lipid metabolism (Table 3) . Both lipogenesis and lipolysis are altered by ST treatment, with effects on lipid synthesis being of major importance if animals are in positive energy balance, whereas effects on lipolysis predominate when animals are at an energy balance near zero or negative. In addition, the effects of ST on lipid metabolism are chronic rather than acute. An acute insulin-like effect of ST has been reported in laboratory animal studies with adipose tissue from ST-deficient animals or animal treated with ST antiserum (77, 82, 157, 161) . However, this is an experimental paradigm that requires a complete absence of ST as a prerequisite (58) . Acute lipolytic effects of ST were also reported in earlier studies (47, 81, 83) . Such effects are never observed in domestic animals using more highly purified preparations of ST (19, 26, 68, 99 (51) . Specifically, the effects of pST to reduce FAS gene expression are of much greater magnitude protein synthesis in muscle (56, 186) . This exquisite orchestration of glucose partitioning by ST reduces glucose than observed for expression of the GLUT4 gene. There is other evidence that corroborates this observation. Poruse for fat deposition in adipose tissue, thereby allowing sufficient glucose to support the increase in muscle pro-cine ST selectively affects the activity of certain lipogenic enzymes more than others (90, 125) . For example, pST tein synthesis in growing animals or the increase in milk synthesis in lactating animals.
markedly reduces FAS and acetyl-CoA carboxylase enzyme activities in adipose tissue; however, the reduction Somatotropin administration dramatically reduces in activity of enzymes in the pentose cycle is considerably fatty acid synthesis in adipose tissue as illustrated by reless (see Table 4 ). Further evidence to support the idea sults from both in vitro (178-180) and in vivo kinetic that pST exerts differential effects is based on metabolic studies (57). In growing pigs, rates of de novo synthesis studies that have been recently conducted (51) . These can be decreased by ú90%, whereas effects on rates of data revealed that the antagonistic effect of pST on insulin lipolysis are minimal. The reduced ability of insulin to action is more potent when glucose transport is maxstimulate lipogenesis in adipose tissue involves a change imized (5 mM glucose) than when glucose concentration in the sensitivity (increased ED 50 ) with no change in the limits glucose entry into the cell (i.e., at 1 mM glucose). maximum response ( Fig. 5 ; Refs. 68, 69). This leads to a This suggests that the effects of pST on lipogenesis are marked decrease in insulin-regulated events such as glumanifested predominantly subsequent to glucose transcose transport, lipogenic enzyme activities, expression of port. This does not mean that pST does not decrease glulipogenic enzyme genes, and lipid synthesis (see Refs. 51, cose transport, since pST clearly reduces glucose uptake 90, 115, 121, 125, 133, 174, 179) .
in pig adipocytes (125) . However, it appears that the effects of pST on glucose transport are secondary to changes in glucose utilization that occur at key metabolic regulatory points subsequent to transport. The decrease in insulin sensitivity caused by pST in pig adipose tissue is not associated with any change in insulin receptor number or tyrosine kinase activity of the insulin receptor (125) . This is consistent with the fact that some effects of insulin in the adipocyte are not diminished by ST treatment (e.g., insulin inhibition of lipolysis). Little is known, however, about the postreceptor events that mediate the effects of pST on the insulin signal pathway(s) to antagonize the stimulatory effect of insulin on expression of lipogenic enzyme genes. Because of this, studies have been undertaken to use the FAS gene as a model to study how ST reduces insulin signaling. This gene is useful to study, since changes in enzyme activity are the result of changes in enzyme protein mass that reflect changes in FAS mRNA abundance (reviewed in Ref. 94 ). In addition, changes in enzyme activity (reflecting changes in gene transcription) are quite sensitive to alterations in insulin status (94) . Because FAS is under exquisite insulin regulation, it is amenable to investigate whether ST affects insulin signaling to the gene. On the basis of the evidence presented previously, it is not surprising that treatment of Table 4 ). Recently, we have found both in rat (90) is a member), tumor necrosis factor-a (TNF-a), has been Acetyl-CoA carboxylase 8.5
1.8 shown to induce insulin resistance in obesity (95, 105).
Fatty acid synthase 27 9
The particularly intriguing aspect of these results is that
Glucose-6-phosphate dehydrogenase 142 67 6-Phosphogluconate dehyrdrogenase 160 84 TNF-a induces serine phosphorylation of IRS-1 that seems Somatotropin affects lipolysis indirectly through alterations in adipose tissue response to acute homeostatic signals that regulate lipolysis. This allows for greater mobilizaliver and cultured 3T3-F442A adipocytes that ST reduces tion of reserves in ST-treated animals when energy is in FAS mRNA abundance as the result of a decrease in gene short supply (Table 3 ). This is especially important during transcription (52, 187) , indicating that the reduction in ST treatment of lactating cows, because animals are gener-FAS mRNA in pig adipocytes also is due to a decrease in ally near zero energy balance when bST treatment is inititranscription. We are unaware of studies, however, that ated, and voluntary intake does not match the enhanced have addressed this question in porcine or bovine adipomilk energy output during the initial phase of the treatment cytes. In large part, this reflects the difficulties of isolating (18, 170). However, ST effects on lipid mobilization are nuclei from these adipocytes to conduct the run-on tranalso observed in growing animals when energy intake is scription analyses and that to date no studies have been restricted (59, 123, 148) . Isotope kinetic studies have demreported in which these cells have been transfected with onstrated that the extent of the increase in fatty acid mobilia chimeric gene containing the FAS promoter linked to a zation with ST treatment is highly correlated with net enreporter gene. Nonetheless, it seems reasonable to specuergy balance and circulating concentrations of nonesterilate that FAS transcription in pig adipocytes may respond fied fatty acids (NEFA) (18, 59). Elevated circulating NEFA to ST in a similar manner.
concentrations are occasionally observed when ST-treated A fundamentally important question that needs to be animals are in positive energy balance. In this case, the answered is, How does ST interfere with insulin signaling? elevated NEFA concentrations relate to the enhanced lipoWith the use of FAS as a model enzyme gene and with lytic response to homeostatic signals in ST-treated animals the presumption that this is applicable to the other key and represent a transitory increase relating to the mild insulin-regulated lipogenic enzyme gene, acetyl-CoA carstress associated with blood sampling (25). boxylase, the following hypotheses emerge: 1) the reducThe regulation of lipolysis involves cAMP and a signal tion in FAS gene transcription is the result of ST interfertransduction system that includes stimulatory G proteins ing with insulin signaling at some point between the insu-(G s ) and inhibitory G proteins (G i ). Catecholamines affect lin receptor and the gene; 2) there is a ST response lipolysis through the G s system, and ST treatment dramatielement in the FAS gene promoter that acts as a negative cally increases the lipolytic response to catecholamines control element to repress insulin-regulated transcription in lactating cows (126, 158) and growing cattle and pigs and interacts with key transcription factors that are ST (25, 140, 148) . This is most evident by the increase in regulated (in this case there is a ST signal pathway to the circulating NEFA when a catecholamine challenge is adgene); or 3) both of these regulatory scenarios occur. At ministered, and the enhanced response involves an inthis juncture, it is not possible to clarify which of these crease in the maximum response (R max ) to catecholamines alternatives account for the suppressive effects of ST on with no change in the sensitivity (Fig. 6) . A similar change insulin stimulation of lipogenesis. Recently, Argetsinger in the dose-response curve occurs in humans receiving et al. (5) reported that ST stimulates tyrosyl phosphoryla-ST treatment (20) . This change in the response to catetion of insulin receptor substrate (IRS)-1, which is a key cholamines is evident within 15 h after the initiation of molecule in insulin signal transduction pathways (136) .
ST treatment (100) and is observed regardless of whether Some have interpreted these findings to suggest that ST signaling involves IRS-1; however, it is difficult to recon-animals are in a positive or negative net energy balance.
06-30-98 12:55:38 pras APS-Phys Rev (54, 97, 181) . Studies with adipose tissue from lactating cows and growing sheep also demonstrated that ST treatment did not alter the abundance of the a-, b-, or g-subunits or the heterotrimeric G i proteins that bind to the adenosine receptors (54, 96) . However, the functionality of the G i proteins, as assessed by their ability to be ADP-ribosylated by pertussis toxin, was significantly reduced with ST treatment (96) . Chronic exposure to ST also prevented the inhibitory effect of low concentrations of guanosine 5-(bg-imido)triphosphate, suggesting that the ability of the a-subunit of G i to interact with adenylyl cyclase was impaired (173). Prostaglandins are additional local controls with the E series known to be antilipolytic via the G i system in rats and humans. Just as with adenosine, ST treatment causes a decreased antilipolytic response to PGE and also decreased PGE 2 production in studies involving microdialysis of subcutaneous adipose tissue of sheep (54) . Overall, results demonstrate that a major mechanism by which ST alters lipolysis centers on the G inhibitory system of adipose tissue. Thus the enhanced lipolytic response to catecholamines observed in vivo in ST-treated animals is in large part related to a relief in the tonic inhibition of lipolysis via changes in the Somatotropin has numerous tissue effects related to Initial studies to examine the mechanism made the carbohydrate metabolism (see Table 3 ). This is of particusurprising observation that the chronic treatment with ST lar importance in the dairy cow in which glucose origiin vivo had no effect on the response of subcutaneous nates almost exclusively from gluconeogenesis and typiadipose tissue to catecholamines in vitro. Although differ-cally 60-80% of the glucose turnover is used for milk ences between adipose tissue depots represented a possi-synthesis. Treatment of cows with bST increases the rate ble partial explanation (175), it became clear that the basis of glucose irreversible loss and reduces whole body glufor this paradox lay elsewhere. Somatotropin treatment, cose oxidation (18). These adaptations in glucose producin vivo or in vitro, resulted in only modest changes in b-and a 2 -adrenergic receptor numbers (53, 54, 97, 181) . Furthermore, examination of the G s proteins and other downstream components of the lipolytic signal transduction cascade demonstrated no differences in adipose tissue from bST-treated and control animals (54, 97). These results raised the possibility that the major mechanism by which ST altered lipolysis might involve the antilipolytic system of adipocytes. Adenosine was a likely candidate because it is an autocrine/paracrine factor that exerts an acute antilipolytic effect via the G i system. Indeed, chronic treatment with ST decreases the antilipolytic effects of adenosine in adipose tissue (53, 54, 96, 115) .
The diminution of adenosine's ability to inhibit lipoly- This is frequently referred to as the biological efficiency creased with ST treatment of dairy cows as demonstrated by in vivo (42) and in vitro studies (109, 149) ( Table 3) . or partial efficiency of amino acid use. An increase in partial efficiency of amino acid utilization of 25 -50% Mechanisms include a decreased ability of insulin to inhibit gluconeogenesis (42) (Table 3) . Thus the reduction has been reported for pST treatment of pigs (27, 33, 35, 112, 139) and bST treatment of growing cattle (98) and in hepatic response to insulin in bST-treated cows allows the liver to sustain an increased rate of gluconeogenesis lambs (21, 124). Thus ST both increases the maximal capacity for protein accretion and increases the partial that is critical to support the increase in the synthesis of milk components. In contrast, ST treatment had no effect efficiency by which amino acids are used for protein deposition. on liver glycogen concentration in lactating cattle in positive energy balance (149), although ST treatment did inConsistent with the improved efficiency of amino acid use, a decrease in blood concentrations of urea duce a small decrease in cows in negative energy balance (109). Liver glycogen reserves are too limited to sustain nitrogen is consistently observed, demonstrating that whole body oxidation of amino acids is reduced with increased glucose output by the liver in lactating cows.
In growing pigs treated with pST, glucose utilization ST treatment. This has been directly demonstrated in isotope kinetic studies with heifers and steers (59, 60) by adipose tissue is markedly reduced as discussed earlier, but use by nonadipose tissues is unaffected (57). and from nitrogen balance studies with pigs and ruminants (137). Especially impressive is that the reduced If treated pigs are in a postabsorptive state, there is an increase in hepatic output of glucose (84) . As with lactat-oxidation of amino acids occurs even when protein and amino acid intake are inadequate to meet requirements. ing cows, the ability of insulin to decrease gluconeogenesis is attenuated in growing pigs and cattle receiving ST Although cellular aspects have not been elaborated, a decrease in hepatic capacity for amino acid catabolism treatment (56, 84) .
has been observed in bST-treated rats (23).
The effects of ST on muscle histochemistry and C. Effects on Protein Metabolism morphology have been well characterized (143, 144, 156, 163, 167, 184) . Most studies have observed that Considerably less is known about the effects of ST on ST treatment enhances hypertrophy of skeletal muscle protein metabolism of domestic animals than for either lipid fibers without changing muscle fiber number. In reor carbohydrate metabolism. It is clear that ST treatment sponse to pST, nuclei proliferation is increased to the increases muscle protein accretion in growing animals and same extent as muscle fiber hypertrophy. This event is milk protein synthesis in lactating cows (Table 3) . However, important because postnatal accretion of DNA is a key the precise mechanisms are not clear, and the extent to factor in regulating muscle growth (3). This increase which the effects of ST on protein metabolism are direct or occurs because of proliferation of satellite cells that mediated by IGF-I remains unclear. There is some informareside between the sarcolemma and basement memtion that suggests IGF-I may mediate the effects of pST on brane of myofibers. These cells have the ability to fuse protein accretion (Fig. 2) . These results indicate that there with the myofiber and thereby contribute their nucleus is a reasonably good relationship between the changes in to the cell. Thus, during postnatal muscle growth, the circulating IGF-I level and protein accretion rate in pSTincrease in muscle DNA is coordinated with the intreated pigs fed diets varying in dietary protein (Fig. 2) . It crease in muscle protein. In addition to the effects of must be emphasized, however, that these results are associa-ST on protein metabolism, changes also occur in the tive data and do not provide any insight as to whether the rate of satellite cell proliferation. Although little inforeffects of ST on protein accretion are mediated totally or in mation is known for domestic animals, it is clear that part by IGF-I. satellite cell proliferation is critically regulated by IGFThe enhanced growth rate with ST treatment of rumi-I. There is considerable information about the effects nants and pigs is due to a more efficient use of absorbed of IGF-I in laboratory animals and cell culture, and the amino acids that is accompanied by a reduction in circueffects of ST and IGF-I on myogenesis are discussed in lating urea nitrogen concentrations and in urinary nitrodepth by Florini et al. (74) . gen loss. The increase in protein accretion is largely the result of increased protein synthesis, whereas protein degradation remains unaltered (24, 59, 60, 80, 147, 159) . How-D. Effects on Mammary Gland Metabolism ever, some have suggested rates of degradation are decreased (168) , and this difference may relate to the Treatment with bST causes a dramatic increase in the uptake and utilization of nutrients for the synthesis of milk methods used to assess degradation.
06-30-98 12:55:38 pras APS-Phys Rev (Table 3) . However, it has proven to be difficult to document des(1-3)-IGF-I stimulate IGFBP production in bovine mammary epithelial cells (128) . specific mechanisms. At the cellular level, the magnitude of the biochemical changes would likely be small, and mamThere are abundant type I and type II IGF receptors in bovine mammary tissue, and IGF-I addition to bovine mary epithelial cells, which are actively secreting milk components, are difficult to maintain in vitro because of their cell culture systems increases casein synthesis (30, 43, 49, 86) . In contrast, attempts to detect ST receptors in bovine high rates of metabolic activity. Nevertheless, the pattern of response to exogenous bST and the change in the shape of mammary tissue have been unsuccessful (2, 78, 106) , and only a very low level of expression of ST receptor mRNA the lactation curve (Fig. 3) indicate that bST effects involve both an increase in the rates of milk component synthesis can be detected (79, 88). Close arterial infusion of the mammary gland with bST had no effect on milk yield per cell and an improved maintenance of secretory cells. Baldwin and Knapp (8) demonstrated that bST-treated cows (127) , whereas close arterial infusion of IGF-I or IGF-II stimulates milk yield (150, 152, 154) . A role for IGF-I is had increased protein synthetic capacity as indicated by an increased RNA per gland. Furthermore, Knight et al. (110) also consistent with observations that IGF-I dramatically increases blood flow to the mammary gland (150, 153), observed that the decline in mammary cell numbers that normally occurs during lactation was prevented in goats that and this effect appears to be mediated by local production of nitric oxide (114, 151) . The lactational response to close received ST for 22 wk.
arterial infusion with IGFs is arguably the strongest eviSeveral studies have measured the effect of in vivo dence that this is the mechanism for the bST effects on ST treatment on the activity of key mammary enzymes the mammary gland. Nevertheless, lactational responses associated with milk synthesis. Anticipated differences to close arterial infusion of the IGFs are much less than are difficult to detect because methods require using a obtained with systemic supply of bST. Thus considerable tissue biopsy, and the mammary glands of ruminants are work remains in establishing the mechanism of action rather heterogeneous in tissue and cell types. However, whereby bST increases milk synthesis and secretion, and studies with cows and goats have reported trends or sigthe specific roles for the IGFs, the IGFBPs, and their pronificant increases in several key enzymes such as acetylteases remain to be delineated. CoA carboxylase, acetyl-CoA synthetase, and FAS (8, 110, 111, 138) . More clear-cut evidence demonstrating the effects of ST on the activity and mRNA level of mammary V. SUMMARY enzymes comes from studies of rats (10, 11) .
Maintaining higher rates of milk synthesis requires a greater nutrient support. Some have suggested that the Somatotropin treatment of domestic animals markincrease in mammary rates of milk synthesis was merely edly enhances the efficiency of nutrient use and perforthe consequence of ST effects on nonmammary tissues mance. Effects are on postabsorptive use of nutrients and that allowed for a greater supply of nutrients to the mam-involve an orchestration of many physiological processes mary gland (102, 107, 132). However, it is clear that simply in different tissues and organs to enable more nutrients increasing nutrient availability by itself does not mimic to be used for lean tissue accretion (during growth) or the effect of bST on lactational performance (30, 146); milk synthesis (during lactation). The mechanism by rather, bST is a homeorhetic control that results in a coor-which ST causes these coordinated effects involves tissuedinated series of changes involving both nutrient supply specific changes in key metabolic pathways as well as and mammary utilization (Table 3 ). This coordination in-alterations in tissue response to homeostatic signals. In cludes a diversion of cardiac output and an increase in many cases, the cellular sites of the alterations in metablood flow to the mammary gland that parallels the magni-bolic pathways and signal transduction have been identitude of the milk response to exogenous bST (48, 76) .
fied, and it is clear that the biological effects of ST are The mechanism by which ST affects mammary gland dependent on multiple changes. However, the molecular function is still uncertain but appears to be indirect, involv-bases of the intracellular ST signal transduction pathways ing the IGF system. As with nonlactating animals, the ad-that alter other signaling pathways that are responsible ministration of exogenous bST increases circulating con-for the homeostatic responses and the mechanisms that centrations of IGF-I and IGF binding protein (IGFBP)-3 and account for the tissue-specific effects are obscure. Neverdecreases circulating IGFBP-2. Furthermore, the magni-theless, it is clear than the overall effects of ST are to tude of changes in circulating IGF-I and the IGFBP closely both enhance the ability of muscle (growth) or mammary parallels the biological events and the magnitude of the tissue (lactation) to utilize nutrients while simultaneously milk responses that occur with bST treatment of dairy coordinating other physiological processes and tissues cows (see reviews in Refs. 19, 29, 130, 131) . In studies with (such as adipose tissue), in a manner that supports this transgenic mice, IGF-I appeared to prevent mammary gland enhanced performance. Although we have learned much about the biology of ST in domestic animals during the involution after lactation (87 
